График акции UroGen Pharma Ltd.
Расширенный график
Простой график
О компании
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102 for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial carcinoma and low-grade non-muscle invasive bladder cancer. подробнее| IPO date | 2017-05-04 |
|---|---|
| ISIN | IL0011407140 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://www.urogen.com |
| Цена ао | 15.17 |
| Изменение цены за день: | -2.54% (11.04) |
|---|---|
| Изменение цены за неделю: | +1.13% (10.64) |
| Изменение цены за месяц: | -15.01% (12.66) |
| Изменение цены за 3 месяца: | -16.59% (12.9) |
| Изменение цены за полгода: | -28.93% (15.14) |
| Изменение цены за год: | -28.27% (15) |
| Изменение цены за 3 года: | +13.74% (9.46) |
| Изменение цены за 5 лет: | -65.05% (30.79) |
| Изменение цены за 10 лет: | 0% (10.76) |
| Изменение цены с начала года: | -15.28% (12.7) |
|
|
Недооценка
|
Эффективность
|
|||||||||||||||||||||||||||||||||||||
Дивиденды
|
Долг
|
Импульс роста
|
|||||||||||||||||||||||||||||||||||||
| Институционалы | Объем | Доля, % |
|---|---|---|
| Great Point Partners LLC | 2620545 | 8.49 |
| Menora Mivtachim Holdings Ltd. | 2303031 | 7.46 |
| RA Capital Management, L.P. | 1483697 | 4.81 |
| Blackrock Inc. | 1197647 | 3.88 |
| Credit Suisse Ag/ | 1060000 | 3.43 |
| Harel Insurance Investments & Financial Services Ltd. | 870194 | 2.82 |
| RTW Investments LP | 857464 | 2.78 |
| Migdal Insurance & Financial Holdings Ltd. | 648302 | 2.1 |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508883 | 1.65 |
| Wildcat Capital Management, LLC | 495606 | 1.61 |
| Руководитель | Должность | Оплата | Год рождения |
|---|---|---|---|
| Ms. Elizabeth A. Barrett | President, CEO & Director | 1.12M | 1962 (63 года) |
| Mr. Dong Kim | Chief Financial Officer | 546.68k | 1977 (48 лет) |
| Mr. Jason Drew Smith | General Counsel, Chief Compliance Officer & Corporate Secretary | 717.58k | 1972 (53 года) |
| Vincent I. Perrone | Senior Director of Investor Relations | N/A | |
| Mr. Bryon Wornson | Executive Vice President of Talent, Advocacy & Communications | N/A | |
| Dr. Mark P. Schoenberg M.D. | Chief Medical Officer | 579.5k | 1958 (67 лет) |
| Mr. James Ottinger R.ph. | Executive Vice President of Regulatory Affairs & Quality | N/A | |
| Dr. Marina Konorty Ph.D. | Executive Vice President of Research & Development and Technical Operations | ||
| Dr. Polly A. Murphy D.V.M., M.B.A., Ph.D. | Chief Business Officer | 1965 (60 лет) | |
| Mr. Michael J. Louie M.D., M.P.H., M.Sc. | Senior Vice President of Medical Affairs & Clinical Development |
Адрес: United States, Princeton. NJ, 400 Alexander Park - открыть в Google картах, открыть Яндекс картах
Сайт: https://www.urogen.com
Сайт: https://www.urogen.com
